Showing results (481-490 of 627) with videos related to

Sort By:
Pageof 63
BJU International|July 5, 2012
Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomyEugene K Lee, Harry W Herr, Rian J Dickstein, et al.
BJU International|October 17, 2013
Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopyPhilip H Kim, Ranjit Sukhu, Billy H Cordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancerH W Herr, V P Laudone, R A Badalament, et al.
Facial Plastic Surgery & Aesthetic Medicine|November 10, 2023
Composite Sterno-Omohyoid Functional Muscle Transfer for Dual-Vector Smile Reanimation: A Case SeriesMarc H Hohman, Joseph S Krivda, Marc W Herr, et al.
BJU International|February 16, 2011
Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapyMatthew G Kaag, Matthew I Milowsky, Guido Dalbagni, et al.
International Scholarly Research Notices|July 20, 2016
Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary ExperienceWassim M Bazzi, Ryan P Kopp, Timothy F Donahue, et al.
International Journal of Hygiene and Environmental Health|February 14, 2007
Assessment of environmental worry in health-related settings: Re-evaluation and modification of an environmental worry scaleTobias Rethage, Dieter Eis, Uwe Gieler, et al.
The Journal of Urology|December 20, 2011
Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinomaJonathan L Silberstein, Nicholas E Power, Caroline Savage, et al.
Medical Oncology (Northwood, London, England)|November 4, 2017
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trialI Walter, U Schulz, M Vogelhuber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladderGuido Dalbagni, Paul Russo, Joel Sheinfeld, et al.
Pageof 63